Gallant
PrivateLast Round
Series B
Jun 30, 2025
Total Funding Raised
$51M
Company Overview
Gallant is a pet health technology company that offers a platform for stem cell therapy, utilizing regenerative medicine to treat future diseases by preserving pets' natural biology and avoiding traditional treatments with challenging side effects.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gallant Comps
Public and private peers based on sector, stage, and business model.
Gallant Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 30, 2025 | ||||
| Series A | Jan 8, 2024 | ||||
| Series A | Oct 24, 2019 | ||||
| Seed | Aug 5, 2019 |
Gallant Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Slow Ventures | Seed |
| Maveron | Series A |
| Digitalis Ventures | Series A, Series B |
| Hill Creek Capital | Series A, Series B |
| BOLD Capital Partners | Seed, Series A, Series B |
| NovaQuest Capital Management | Series B |
| Bold Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 27, 2026
Partnering with MWI Animal Health for ultra-low temperature cold chain logistics.
- Sep 15, 2025
Launched GallantU, an online continuing education platform for veterinary professionals.
Gallant Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gallant's valuation, stock price, and market status.
